PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Competing in the U.S. Contract Research Market - Frost & Sullivan's Healthcare Division will be releasing an end-user study later this month on the increasingly competitive landscape of the CRO market
Competing in the U.S. Contract Research Market


NewswireToday - /newswire/ - Palo Alto, CA, United States, 2006/11/09 - Frost & Sullivan's Healthcare Division will be releasing an end-user study later this month on the increasingly competitive landscape of the CRO market.

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


The study, entitled "Competing in the U.S. Contract Research Market: What Pharma & Biotech Companies Want and How to Compete for their Business" is the result of extensive interviews conducted across Pharmaceutical and Biotech companies, and provides insights on how CROs are evaluated within a scenario of tightening outsourcing budgets.

Outsourcing to CROs by pharmaceutical and biotechnology companies continues to be a growing trend with more than 20 percent of cardiovascular and oncology clinical development currently being outsourced. Additionally, therapeutic areas such as metabolic diseases are likely to be increasingly outsourced in the next 12-24 months.

Due to increased globalization of clinical trial activity, there is indication of a possible slight shift in clinical trial activities from North America to other regions. North America's share of clinical trials is expected to decrease from 61 percent to 53 percent in the next 3-5 years.

The primary reasons for outsourcing include a reduction in manpower required by pharmaceutical and biotech firms, greater geographic coverage provided by CROs, better access to patients for clinical trials and an enabling of R&D in non-core therapeutic areas.

Furthermore, there is some indication of a trend towards significant reductions in outsourcing / CRO budgets in the next 12 to 24 months for the majority of pharmaceutical and biotechnology companies surveyed. The source of this reduction appears to be an overall expectation of decline in outsourcing costs, most likely due to intensifying competition, rather from a decline in the rate of outsourcing itself.

Frost & Sullivan’s comprehensive end-user study on the CRO Market will include the following elements:

• Analysis of various Contract Research Organization (CRO) market segments: The study identifies and describes 3 market segments, derived statistically, in terms of their breadth, scope and intensity of outsourcing, perceived motives for outsourcing, and criteria for CRO selection.

• Perceived strengths of the largest CROs: The study evaluates the perceived positioning of 11 large CROs, based on how they are associated with various key attributes.

• Data and Information on Selection Criteria of CROs: This study encompasses vital feedback allowing CROs to gain insight into current and future outsourcing patterns and trends, to better understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements.

• Varied sample of respondents: The sample includes representatives of both Pharmaceutical (65%) and Biotechnology Companies (35%). The 180 respondents were involved either in R&D, Clinical Development, Product Management, Purchasing, Quality Control, or Regulatory functions.

• Proven survey methods: The study includes survey methods such as ANOVA, MaxDiff, Cluster Analysis, Factor Analysis, Correspondence Analysis, Multiple Regression, and Logistic Regression.

If you are interested in a complimentary brochure, which provides an overview of this informative End-User Study on the CRO Market, please send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.] with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Additionally, respond by November 21st to receive promotional pricing on a CRO research bundle, which includes the End User study as well as a CRO Market Engineering study.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!

Competing in the U.S. Contract Research Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Melina Trevino 
210.247.2440 melina.trevino[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Research Most Recent Related Newswires:

DSM High-temperature Plastics Successfully Replace Metal in Charge Air Cooler End Cap Application
DSM Developing Novel Materials Solution for High-pressure Composite Tanks for Hydrogen Storage
DSM Brings Digestive Comfort to Gluten Sensitive Adults with Launch of Unique Enzyme
DSM Announces Exclusive Partnership with Nanjing Cosmos Chemical Co., Ltd and Plans to Continue Expansion in UV Filters
DSM Launches New Enzyme Solutions At IFT17 to Improve Softness and Moistness of Gluten-free Bread
DSM and Evonik Select Nebraska for Production of Breakthrough Omega-3
Phasor to Develop Next Generation Electronically Steerable Antenna Featuring DSM Dyneema’s Advanced Radome Solution
DSM’s Delvotest® T Antibiotic Residue Test for Milk Validated by Finnish Food Safety Authority
Royal DSM to Make Equity Investment in Amyris with the Purpose of Establishing A Long-term Relationship
DSM Unveils New Beauty Active At NYSCC Suppliers’ Day
Iridea Bio - A New Sustainable Paint Made with DSM’s Decovery® Plant-based Resin
DSM to Showcase A Wide Range of Innovative Composite Solutions
DSM’s New Protective Delvo®Guard Cultures Reduce Food Waste in Dairy
DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids from Natural Marine Algae for Animal Nutrition
DSM Introduces Dyneema Purity® Black Fiber - The First Black Medical-grade UHMWPE Fiber

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  NAKIVO, Inc.


  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (